| pubmed-article:21674712 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0021853 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0681698 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C1414461 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0678257 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0205549 | lld:lifeskim |
| pubmed-article:21674712 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:21674712 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:21674712 | pubmed:dateCreated | 2011-6-15 | lld:pubmed |
| pubmed-article:21674712 | pubmed:abstractText | Primary intestinal lymphoma in the setting of inflammatory bowel disease (IBD) is uncommon and may be associated with immune suppressive therapy. We report clinical features and outcomes in patients with both conditions prior to use of biologic therapy. | lld:pubmed |
| pubmed-article:21674712 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21674712 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21674712 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21674712 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21674712 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:21674712 | pubmed:issn | 1536-4844 | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:HarmsenW... | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:LoftusEdward... | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:CimaRobert... | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:LarsonDavid... | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:WolffBruce... | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:DozoisEric... | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:TehSwee HSH | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:HolubarStefan... | lld:pubmed |
| pubmed-article:21674712 | pubmed:author | pubmed-author:BenaventeLuis... | lld:pubmed |
| pubmed-article:21674712 | pubmed:copyrightInfo | Copyright © 2010 Crohn's & Colitis Foundation of America, Inc. | lld:pubmed |
| pubmed-article:21674712 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21674712 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:21674712 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21674712 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21674712 | pubmed:pagination | 1557-63 | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:meshHeading | pubmed-meshheading:21674712... | lld:pubmed |
| pubmed-article:21674712 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21674712 | pubmed:articleTitle | Primary intestinal lymphoma in patients with inflammatory bowel disease: a descriptive series from the prebiologic therapy era. | lld:pubmed |
| pubmed-article:21674712 | pubmed:affiliation | Division of Colon and Rectal Surgery, Dartmouth-Hitchcock Medical Center, Lebanon NH 03756, USA. | lld:pubmed |
| pubmed-article:21674712 | pubmed:publicationType | Journal Article | lld:pubmed |
